Category: Cancer Treatment
United States Cancer Treatment
-
North America Cancer Diagnostics Market, By Products (Instruments, Consumables Services), By Test Type (Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Immunohistochemistry, In Situ Hybridization and Others (Endoscopy, Genetic Tests)), By Application (Breast Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United ... Read More
-
2024 Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Te
... TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), ... Read More
-
2024 North America Clinical Chemistry and Immunodiagnostics Market in the US, Canada and Mexico - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein
... Immunoprotein and TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, ... Read More
-
U.S. Cancer Contrast Media Market Size, Share & Trends Analysis Report By Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), By Modality (Nuclear Imaging, CT scans), By Application (Breast Cancer, Lung Cancer), And Segment Forecasts, 2024 -
... - U.S. Cancer Contrast Media Market Growth & Trends The U.S. cancer contrast media market is anticipated to reach USD 1.53 billion by 2030 and is anticipated to expand at a CAGR of 11.7% from ... Read More
-
Oncologists Global Market Opportunities And Strategies To 2032 Including: 1) By Cancer Diagnosis And Treatment: Cancer Diagnosis; Cancer Treatment 2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head And Neck Cancer; Prostate Cancer 3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia Covering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, Inc.
... Cancer3) By Service Provider: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; AcademiaCovering: Kaiser Foundation Health Plan, Inc.; HCA Healthcare, Inc.; The University of Texas MD Anderson Cancer Center; Tenet Healthcare Corporation; Universal Health Services, ... Read More
-
NA Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2035
... to 2031. The new market report contains data for the historic year 2022, the base year of calculation is 2023, and the forecast period is 2024 to 2031. Market Segmentation North America Acute Myeloid Leukemia ... Read More
-
U.S. Prostate Cancer Nuclear Medicine Diagnostics Market Size, Share & Trends Analysis Report By Type (SPECT, PET), By PET Product (F-18, SR-82/RB-82), And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. prostate cancer nuclear medicine diagnostics market size is expected to reach USD 153.97 million by 2030, according to a new report by Grand View Research, Inc. It is anticipated to ... Read More
-
US and Europe Metastases Spinal Tumor Market Research Report Forecast to 2030
... launch of the research start-up programme. However, the side effects associated with spine tumor treatments are anticipated to hamper the market growth. Metastatic spinal tumors are abnormal tissue clusters that can develop in the spine ... Read More
-
US Acute Myeloid Leukemia Market to 2028
... in Research and Development, and a constant growth in population. Advancement in therapeutic approaches, including targeted therapies, immunotherapies, checkpoint inhibitors, and personalized medicines, have revolutionized AML treatment, boosting patient satisfaction and reducing side effects. Rising ... Read More
-
US Kidney Cancer Therapeutics and Diagnostics Market to 2028
... increase in success rate of targeted therapies, expansion of hospitals and NCI- funded cancer centers, and constant growth in population. Advancement in therapeutic approaches, including targeted therapies, immunotherapies, checkpoint inhibitors, and personalized medicines, have revolutionized ... Read More
-
United States Diagnostics Market By Product Type (Reagents, Instruments, Software & Services), By Type of Test (Infectious Disease Testing, Lipid Panel, Metabolic Panel, Others), By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others), By Usability (Reusable, Disposable), By Application (Infectious Diseases {Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19}, Cancer, Sexually Transmitted Diseases, Others), By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F
... Usability (Reusable, Disposable), By Application (Infectious Diseases {Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19}, Cancer, Sexually Transmitted Diseases, Others), By End User (Hospitals, Public labs, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others), ... Read More
-
2023-2027 U.S. Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 North America Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - US, Canada, Mexico - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 3-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
United States Prostate Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... States market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the United States market. Also, factors that are driving and restraining the prostate cancer market are highlighted in the ... Read More
-
United States Pancreatic Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... States market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the United States market. Also, factors that are driving and restraining the pancreatic cancer market are highlighted in the ... Read More
-
US and Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral Vectors and Non-Viral Vectors)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country
... Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country The US and Europe cell and gene therapy manufacturing services market was valued at ... Read More
-
United States Women Health Laboratory Testing Market By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer), By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing), By Region, Competition Forecast & Opportunities, 2018-2028
... Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing), By Region, Competition Forecast ... Read More
-
United States CAR-T Cell Therapy Market By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Tecartus (Brexucabtagene Autoleucel), Breyanzi (Lisocabtagene Maraleucel), Abecma (Idecabtagene Vicleucel), Others), By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2028.
... B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User ... Read More
-
United States Prostate Cancer Testing Market By Biomarker Type (Pre-Biopsy/Post-Negative Biopsy Testing, Initial Evaluation: Prostate-Specific Antigen (Total PSA, Free PSA), Post-Biopsy Tissue Testing), By Application (Diagnostics Biomarkers, Prognostics Biomarkers), By End User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals and Clinics, Ambulatory Surgical Center (ASCs), and Others), By Region, Competition Forecast & Opportunities, 2018-2028
... Diagnostic Laboratories, Hospitals and Clinics, Ambulatory Surgical Center (ASCs), and Others), By Region, Competition Forecast & Opportunities, 2018-2028 United States Prostate Cancer Testing Market is expected to grow at an impressive rate during the forecast ... Read More
-
US Helicobacter Pylori Non-Invasive Testing Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Test Type (Urea Breath, Test Method, and Serology), Test Method (Laboratories Based and Point of Care), and End User (Hospitals, Reference Laboratories, and Others)
... (Hospitals, Reference Laboratories, and Others) The US Helicobacter Pylori Non-Invasive Testing Market size is expected to grow from US$ 223.76 million in 2022 to US$ 302.79 million by 2028; it is estimated to record a ... Read More
-
United States of America (USA) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... Forecast to 2030 Summary GlobalData’s “United States Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United States Embolization Particle Procedures. The databook report provides procedure volumes ... Read More
-
U.S. Minor Cannabinoids Market Size, Share & Trends Analysis Report By Product (Cannabigerol (CBG), Tetrahydrocannabivarin (THCV)), By Application (Cancer, Inflammation, Pain Management), And Segment Forecasts, 2023 - 2030
... The U.S. minor cannabinoids market size is expected to reach USD 33.3 billion by 2030, expanding at a CAGR of 16.4% over the forecast period, according to a new report by Grand View Research, Inc. ... Read More
-
U.S. Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2030. Market Segmentation U.S. Pancreatic Cancer Diagnostics Market, By Test ... Read More
-
2023 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The ... Read More
-
United States Solid Tumor Testing Market, By Type (Conventional Testing, Non-Conventional Testing (Fluorescence in-situ hybridization (FISH), Immunohistochemistry (IHC), Polymerase chain reaction (PCR), and Next-generation sequencing (NGS)); By Cancer Type (Prostate, Breast, Endometrial, Lung, Brain, Others); By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic Research Institutes), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic Research Institutes), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 United States Solid Tumor Testing Market Size Expanding to Reach USD 10.3 Billion ... Read More
Research Assistance
